Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Computer Methods and Programs in Biomedicine, 2021
Artificial Intelligence-Based Prediction of Covid-19 Severity on the Results of Protein Profiling

Yaşar ?., Çolak C., Yoloğlu S.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Frontiers in Bioengineering and Biotechnology, 2021
A LCMS Metabolomic Workflow to Investigate Metabolic Patterns in Human Intestinal Cells Exposed to Hydrolyzed Crab Waste Materials

Ó Fearghail F., Behan P., Engström N. et al.

Olink Target 96Technical StudiesPathophysiologyTechnical EvaluationCell Lysate

Cardiovascular Ultrasound, 2021
Pre- and postoperative left atrial and ventricular volumetric and deformation analyses in severe aortic regurgitation

Jenner J., Ilami A., Petrini J. et al.

Olink Target 96CVDPathophysiologyPlasma

Cancer Research, 2021
Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer

Dagnino S., Bodinier B., Guida F. et al.

Olink Target 96OncologyPatient StratificationPlasma

Scientific Reports, 2021
Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer

Jackson S., Van De Wyngard V., Pfeiffer R. et al.

Olink Target 96OncologyPatient StratificationSerum

Clinical Cancer Research, 2021
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Monjazeb A., Giobbie-Hurder A., Lako A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum

Nature Medicine, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Rozeman E., Hoefsmit E., Reijers I. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Journal of Inherited Metabolic Disease, 2021
Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures

Abdennadher M., Inati S., Soldatos A. et al.

Olink Target 96NeurologyPathophysiologyCSF

Experimental Gerontology, 2021
The oral microbiome and inflammation in mild cognitive impairment

Yang I., Arthur R., Zhao L. et al.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

Psychoneuroendocrinology, 2021
Autoantibodies against the C-terminus of Lipopolysaccharide binding protein are elevated in young adults with psychiatric disease

Just D., Rasmusson A., Nilsson P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

International Journal of Molecular Sciences, 2021
Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis

de Jesús-Gil C., Sans-de San Nicolàs L., Ruiz-Romeu E. et al.

Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPathophysiologyPlasma

PLOS Medicine, 2021
Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study

Chua W., Law J., Cardoso V. et al.

CVDPatient StratificationPlasma

Journal of Crohn's and Colitis, 2021
TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn’s Disease Patients

Caër C., Gorreja F., Forsskåhl S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyCell Culture Supernatant

The American Journal of Cardiology, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)

Hussain A., Tang O., Sun C. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

The Journal of Infectious Diseases, 2021
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19

Janssen N., Grondman I., de Nooijer A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Journal of Allergy and Clinical Immunology, 2021
Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Renert-Yuval Y., Thyssen J., Bissonnette R. et al.

Immunological & Inflammatory DiseasesReview/editorial

The Journal of Infectious Diseases, 2021
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C

Khera T., Du Y., Todt D. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

ERJ Open Research, 2021
Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study

Majewski S., Zhou X., Miłkowska-Dymanowska J. et al.

Olink Target 96Respiratory DiseasesTechnical EvaluationBALFSerum

International Journal of Molecular Sciences, 2021
Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer

Bhardwaj M., Terzer T., Schrotz-King P. et al.

Olink Target 96OncologyTechnical EvaluationPlasma

Journal of Clinical Investigation, 2021
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

Falck-Jones S., Vangeti S., Yu M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

3526 publications